This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Guardant Health’s 8K filing here.
About Guardant Health
Guardant Health, Inc, a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers.
Further Reading
- Five stocks we like better than Guardant Health
- Profitably Trade Stocks at 52-Week Highs
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- 3 REITs to Buy and Hold for the Long Term
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Stock Market Upgrades: What Are They?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
